AXIM BIOTECHNOLOGIES, INC. (AXIM) Total liabilities 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) total liabilities at each fiscal year-end, per SEC filings.
$11.8MFY2023 · since FY2014: $1.3M → $11.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $11.8M | +30.3% |
| FY2022 | $9.0M | +18.0% |
| FY2021 | $7.7M | -21.4% |
| FY2020 | $9.7M | +15.3% |
| FY2019 | $8.5M | +3.4% |
| FY2018 | $8.2M | -3.6% |
| FY2017 | $8.5M | +121.9% |
| FY2016 | $3.8M | +29.2% |
| FY2015 | $3.0M | +124.1% |
| FY2014 | $1.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice